Variant NM_000492.4:c.1766+152T>A
Name | NM_000492.4:c.1766+152T>A |
Protein name | NP_000483.3:p.(=) |
Genomic name (hg19) | chr7:g.117230645T>A UCSC |
#Exon/intron | intron 13 |
Legacy Name | 1898+152T/A |
Class | non disease-causing |
WT sequence | GCATGGTATTAACTCAAATCTGATC T GCCCTACTGGGCCAGGATTCAAGAT |
Mutant sequence | GCATGGTATTAACTCAAATCTGATC A GCCCTACTGGGCCAGGATTCAAGAT |
Not found | dbSNP rs4148711 |
Not found |
69 individuals carrying this variant are reported in CFTR-NGS catalogue |
TOTAL NUMBER OF PATIENTS | 98 |
---|---|
Asymptomatic compound heterozygote | 1 |
CF | 24 |
CFTR-RD | 65
|
Pending (NBS) | 8 |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
Phenotype | Patient ID | Variant status | Additional variants |
---|---|---|---|
CF | 863 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 882 | heterozygote | VUS3- Undef CF-causing- Undef |
CF | 909 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CF | 808 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CF | 816 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 829 | heterozygote | CF-causing- Undef varying clinical consequence- Undef VUS3- Undef |
CF | 835 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 920 | heterozygote | VUS2- Undef CF-causing- Undef CF-causing- Undef |
CF | 975 | heterozygote | CF-causing- Undef VUS3- Undef |
CF | 1228 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 943 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
CF | 945 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 947 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CF | 663 | heterozygote | VUS2- Undef CF-causing- Undef varying clinical consequence- Undef |
CF | 686 | heterozygote | VUS3- Undef |
CF | 691 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 4697 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 4665 | heterozygote | VUS3- Undef CFTR-RD-causing- Undef |
CF | 716 | heterozygote | CF-causing- Undef CF-causing- Undef |
CF | 4688 | homozygote | c.1519_1521del - p.(Ile507del) - Trans c.2657+5G>A - p.(=) - Trans |
CF | 977 | homozygote | c.680T>G - p.(Leu227Arg) - Trans |
CF | 316 | homozygote | c.1657C>T - p.(Arg553*) - Trans c.870-1113_870-1110del - p.(=) - Trans |
CF | 901 | homozygote | c.2657+5G>A - p.(=) - Trans |
CF | 730 | homozygote | c.3131A>G - p.(Glu1044Gly) - Trans |
Other | 972 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
Other | 935 | heterozygote | CFTR-RD-causing- Undef |
Other | 940 | heterozygote | CF-causing- Undef |
Other | 4695 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef |
Other | 789 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
Other | 4686 | heterozygote | VUS3- Undef CF-causing- Undef |
Other | 4671 | homozygote | c.1585-9449C>A - p.(=) - Trans c.2002C>T - p.(Arg668Cys) - Trans |
Other | 4627 | homozygote | c.2002C>T - p.(Arg668Cys) - Trans c.2657+2_2657+3insA - p.(=) - Trans |
CBAVD | 858 | heterozygote | |
CBAVD | 887 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef |
CBAVD | 892 | heterozygote | CFTR-RD-causing- Undef varying clinical consequence- Undef CFTR-RD-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 893 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 894 | heterozygote | varying clinical consequence- Undef VUS3- Undef |
CBAVD | 900 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 857 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 840 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 837 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
CBAVD | 805 | heterozygote | VUS1- Undef |
CBAVD | 806 | heterozygote | VUS3- Undef |
CBAVD | 812 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef |
CBAVD | 818 | heterozygote | |
CBAVD | 834 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 912 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 978 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 986 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef |
CBAVD | 1248 | heterozygote | CFTR-RD-causing- Undef CFTR-RD-causing- Undef CF-causing- Undef |
CBAVD | 3125 | heterozygote | CF-causing- Undef VUS1- Undef varying clinical consequence- Undef |
CBAVD | 949 | heterozygote | VUS3- Undef CF-causing- Undef |
CBAVD | 931 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 938 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef |
CBAVD | 941 | heterozygote | VUS4- Undef CF-causing- Undef |
CBAVD | 675 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 676 | heterozygote | VUS3- Undef |
CBAVD | 682 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 4683 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 659 | heterozygote | CFTR-RD-causing- Undef CFTR-RD-causing- Undef VUS3- Undef |
CBAVD | 4707 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
CBAVD | 4722 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 690 | heterozygote | |
CBAVD | 423 | heterozygote | VUS3- Undef |
CBAVD | 643 | heterozygote | CFTR-RD-causing- Undef varying clinical consequence- Undef |
CBAVD | 4679 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 658 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 710 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 728 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 868 | heterozygote | CF-causing- Undef likely CFTR-RD- Undef |
CBAVD | 746 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 763 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 765 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
CBAVD | 781 | heterozygote | VUS3- Undef |
CBAVD | 717 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 720 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 721 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 724 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
CBAVD | 701 | homozygote | c.350G>A - p.(Arg117His) - Trans |
CBAVD | 919 | homozygote | c.1210-34_1210-6TG[11]T[5] - Trans c.1684G>A - p.(Val562Ile) - Trans c.3846G>A - p.(Trp1282*) - Trans |
CBAVD | 881 | homozygote | c.1210-34_1210-6TG[11]T[5] - Trans c.617T>G - p.(Leu206Trp) - Trans |
CBAVD | 725 | homozygote | c.1210-34_1210-6TG[11]T[5] - Trans c.1684G>A - p.(Val562Ile) - Trans c.3846G>A - p.(Trp1282*) - Trans |
Pancreatitis | 4692 | heterozygote | varying clinical consequence- Undef CFTR-RD-causing- Undef |
Pancreatitis | 648 | heterozygote | CFTR-RD-causing- Undef CF-causing- Undef |
Pending (NBS) | 803 | heterozygote | VUS2- Undef CF-causing- Undef |
Pending (NBS) | 991 | heterozygote | CFTR-RD-causing- Undef varying clinical consequence- Undef CFTR-RD-causing- Undef |
Pending (NBS) | 951 | heterozygote | VUS2- Undef CF-causing- Undef likely CF- Undef |
Pending (NBS) | 4694 | heterozygote | CF-causing- Undef CFTR-RD-causing- Undef |
Pending (NBS) | 646 | heterozygote | varying clinical consequence- Undef CF-causing- Undef |
Pending (NBS) | 794 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
Pending (NBS) | 726 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
Pending (NBS) | 799 | heterozygote | CF-causing- Undef varying clinical consequence- Undef |
Bronchiectasis | 2838 | heterozygote | CFTR-RD-causing- Undef CFTR-RD-causing- Undef |
Bronchiectasis | 966 | heterozygote | VUS3- Undef VUS3- Undef |
Bronchiectasis | 693 | homozygote | c.137C>A - p.(Ala46Asp) - Trans c.350G>A - p.(Arg117His) - Trans c.580-92T>A - p.(=) - Trans |
Bronchiectasis | 777 | homozygote | c.1210-34_1210-6TG[11]T[5] - Trans c.1684G>A - p.(Val562Ile) - Trans |
Asymptomatic compound heterozygote | 922 | heterozygote | VUS3- Undef |
CRS-NP | 3161 | heterozygote | CF-causing- Undef VUS1- Undef varying clinical consequence- Undef |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
CFTR variants are clustered into five groups: |
|